NCT06930547 Effectiveness of Smoking Cessation Education
| NCT ID | NCT06930547 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Erzurum Technical University |
| Condition | Tobacco Use Disorder |
| Study Type | INTERVENTIONAL |
| Enrollment | 60 participants |
| Start Date | 2024-12-05 |
| Primary Completion | 2025-05-05 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 60 participants in total. It began in 2024-12-05 with a primary completion date of 2025-05-05.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Smoking is an important psychosocial problem that concerns society. It is reported that 1.3 billion people use tobacco products in the world and approximately 6 million people lose their lives due to smoking every year. Despite the high mortality rate, smoking addiction is shown as one of the biggest preventable diseases and causes of death. Individuals with mental health problems have a much higher smoking rate than the general population. Studies show that people with severe mental disorders such as schizophrenia, bipolar disorder and major depression have a smoking rate three to four times higher than the general population. It has been reported that this high smoking rate is associated with more morbidity, mortality and increased healthcare costs in individuals with severe mental disorders. It is reported that nurses, who spend the most time with patients and constitute the largest group of healthcare personnel, have an effective role in smoking cessation initiatives. The importance of nurses in tobacco control is emphasized in the publication titled "Nurses for a Tobacco-Free Life" by the International Council of Nursing (ICN). Although both national and international literature demonstrates that smoking is a serious problem in individuals with severe mental illness through descriptive research results, it is seen that smoking cessation intervention studies are quite limited. Randomized controlled intervention studies examining the effectiveness of smoking cessation interventions applied by nurses to individuals with severe mental illnesses could not be found in the literature. This study will be conducted to examine the effectiveness of smoking cessation education in patients registered in a community mental health center. In light of this information, this study was planned as a randomized controlled study to examine the effectiveness of smoking cessation education in patients registered in a community mental health center. The data obtained from this study will reveal the effectiveness of smoking cessation education in individuals with severe mental illnesses and contribute to filling the gap in the literature in this area. In addition, a method for using smoking cessation education in individuals with severe mental illnesses will be presented with a high level of evidence study.
Eligibility Criteria
Inclusion Criteria: * Being registered with TRSM (Community Mental Health Center) * Being in the remission phase (the period after the patient's treatment is completed, with no observed active symptoms and improved insight) * Smoking at least one cigarette per day regularly * Being open to communication and collaboration * Being over the age of 18 * Volunteering to participate in the study. Exclusion Criteria: * Not being registered with TRSM (Community Mental Health Center) * Not being in the remission phase (presence of active symptoms or lack of improved insight) * Smoking less than one cigarette per day * Being unwilling or unable to communicate and collaborate effectively * Being under the age of 18 * Not volunteering or unwilling to participate in the study.
Contact & Investigator
Zeynep ÖZTÜRK, PHD
PRINCIPAL INVESTIGATOR
Erzurum Technical University
Frequently Asked Questions
Who can join the NCT06930547 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Tobacco Use Disorder. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06930547 currently recruiting?
Yes, NCT06930547 is actively recruiting participants. Contact the research team at zeynepolcun6@gmail.com for enrollment information.
Where is the NCT06930547 trial being conducted?
This trial is being conducted at Erzurum, Turkey (Türkiye).
Who is sponsoring the NCT06930547 clinical trial?
NCT06930547 is sponsored by Erzurum Technical University. The principal investigator is Zeynep ÖZTÜRK, PHD at Erzurum Technical University. The trial plans to enroll 60 participants.